Form D · Pharmaceuticals

Tioma Therapeutics, Inc.

Brisbane, CA · CIK 0001630680

Offering snapshot reported Aug 17, 2016 · SEC filing

Reported sold
$33.2M
Offering amount: $86.3M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 25, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$16.6M$33.2MAug 7, 2015: $8,134,451.00Aug 7, 2015Aug 17, 2016: $33,176,948.00Aug 17, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$8,134,451 → $33,176,948
  • Reported investors10 → 12
  • Minimum accepted$50,000 → $0

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 17, 2016Amendment$33,176,948$25,042,497vs Aug 7, 201512SEC filing
Aug 7, 2015Initial$8,134,451No comparison10SEC filing
Feb 12, 2015Initial$1,269,350No comparison3SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-245292
Issuance and sale of shares of Series A Preferred Stock and the underlying shares of Common Stock issuable upon conversion thereof.

Source: Form D, filed Aug 17, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kalthleen L. Beckmann Executive
Kathleen L. Beckmann Executive
Charles Bolten Director
Dan Broderick Director
George Capps Executive
Jill Carroll Director
John Donovan Director, Executive
William Frazier Director
Robert W. Karr Executive
Pamela T. Manning Executive
John Mc Kearn Director
Peter Moldt Director
Carole L. Nuechterlein Director
Bobby W. Sandage, Jr. Director
James Stutz Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2000 Sierra Point Parkway, Suite 700
Brisbane, CA, 94005